cetuximab
Showing 1 - 25 of 558
Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- Crisaborole Ointment
- Cetuximab
-
Guangzhou, Guangdong, ChinaWeiWei Xiao
Nov 3, 2023
Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)
Not yet recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Xevinapant
- +3 more
- (no location specified)
Jul 3, 2023
Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2023
Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- +2 more
- BET Bromodomain Inhibitor ZEN-3694
- +6 more
- (no location specified)
Oct 25, 2023
Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)
Not yet recruiting
- Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
- Cetuximab
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Oct 24, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)
Not yet recruiting
- Head Neck
- Squamous Cell Carcinoma of Head and Neck
- Pembrolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 14, 2023
Colorectal Cancer Liver Metastases Trial in Shanghai (Cetuximab)
Not yet recruiting
- Colorectal Cancer Liver Metastases
- Cetuximab
-
Shanghai, Shanghai, China
- +1 more
May 22, 2023
Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)
Not yet recruiting
- Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
- HMBD-001
- +2 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 20, 2023
Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)
Not yet recruiting
- Colorectal Cancer
- Non-Small Cell Lung Cancer
- GDC-1971
- +2 more
- (no location specified)
Jul 12, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- Capecitabine
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Advance NSCLC Trial (GFH925, Cetuximab)
Not yet recruiting
- Advance Non-small Cell Lung Cancer
- GFH925
- Cetuximab
- (no location specified)
Mar 7, 2023
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)
Recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck
- Cetuximab
- Imatinib
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Apr 24, 2023
Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,
Not yet recruiting
- Colon Adenocarcinoma
- +4 more
- Encorafenib
- +5 more
- (no location specified)
Jan 24, 2023
Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)
Not yet recruiting
- Colon Cancer
- Colorectal Cancer
- MRTX849
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Cancer of Colon Trial in Jerusalem (Cetuximab)
Terminated
- Cancer of Colon
- Cetuximab
-
Jerusalem, IsraelHadassah Ein Kerem
Aug 2, 2022
Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)
Recruiting
- Squamous Cell Cancers of the Head and Neck
- cetuximab
- afatinib
-
New Haven, ConnecticutYale Cancer Center
Jan 10, 2023
Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston
Active, not recruiting
- Metastatic Colorectal Carcinoma
- +4 more
- Cetuximab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 4, 2022
Recurrent Head Neck Cancer, Head Neck Cancer, Head and Neck Tumors Trial in Cincinnati (Durvalumab, Cetuximab)
Active, not recruiting
- Recurrent Head and Neck Cancer
- +3 more
- Durvalumab
- Cetuximab
-
Cincinnati, OhioUC Health
Oct 3, 2022
Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Cetuximab
- PD 0332991
-
Atlanta, Georgia
- +4 more
Nov 1, 2022
Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)
Active, not recruiting
- Head and Neck Cancer
- Locally Advanced
- Palbociclib
- +2 more
-
Bangkok, ThailandFaculty of Medicine, Ramathibodi Hospital
Sep 19, 2022
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
- Nivolumab
- Cetuximab
-
Tampa, Florida
- +2 more
Dec 30, 2022